Helping Latinas get regular breast cancer screenings
MADRE (Mammograms Available Due to Research and Education)
This study is testing two different ways to help Latinas get regular breast cancer screenings, one using traditional education and the other using support from their social networks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 40 Years to 74 Years |
| Sex | Female |
| Sponsor | University of Illinois at Chicago Academic / other |
| Locations | 2 sites (Chicago, Illinois and 1 other locations) |
| Trial ID | NCT05841355 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to improve breast cancer screening rates among Latinas by comparing two approaches: traditional education and an empowering method that leverages social networks. The study will utilize a longitudinal randomized clinical trial design, integrating social network analysis and implementation science to assess the long-term effects of these interventions. Participants will include non-adherent Latinas who will be encouraged to obtain guideline-concordant initial and repeat screenings. The trial will also explore the psychosocial and network mechanisms that may enhance the effectiveness of the interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are Latinas aged 52-74 who have not adhered to breast cancer screening guidelines and have no previous history of breast cancer.
Not a fit: Patients who do not identify as Latina or who have a history of breast cancer or health volunteerism may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly increase breast cancer screening rates among Latinas, leading to earlier detection and better health outcomes.
How similar studies have performed: Previous studies have shown promise in using community-based approaches to improve screening rates, but this specific integration of social network analysis and implementation science is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Aim 1 Inclusion Criteria: * female biological sex * identification as Latinas * non-adherence to USPSTF guidelines (42-74 years old, no mammogram in past 2 years, no previous BC diagnosis) * no previous history of health volunteerism * not a network member enrolled in Aim 2. Exclusion Criteria \* Not meeting at least one of the aforementioned Aim 1 inclusion criteria. Aim 2. Inclusion Criteria: * female biological sex * eligibility to obtain BC screenings by USPSTF guidelines (i.e., 40-74 years old, no personal BC history) * referral from Aim 1 participants * no previous history of health volunteerism * no participation in the RCT (not an Aim 1 participant, no Session #3 attendance). Exclusion Criteria: * Not meeting at least one of the aforementioned Aim 1 inclusion criteria.
Where this trial is running
Chicago, Illinois and 1 other locations
- Mile Square Health Center — Chicago, Illinois, United States (Recruiting)
- University of Illinois Health — Chicago, Illinois, United States (Recruiting)
Study contacts
- Study coordinator: Yamile Molina, PhD
- Email: ymolin2@uic.edu
- Phone: 312-355-2679
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.